Thyroid Cancer Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Nodules - Full Text View

Sponsors and Collaborators:	University of Nebraska National Cancer Institute (NCI)
Information provided by:	National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:	NCT00693368

Purpose

RATIONALE: Gathering information about patients with thyroid cancer or thyroid nodules may help the study of thyroid cancer in the future.

PURPOSE: This study is gathering information and tissue and blood samples from patients with thyroid cancer or thyroid nodules.

Condition	Intervention
Head and Neck Cancer	Procedure: biologic sample preservation procedure Procedure: medical chart review Procedure: psychosocial assessment and care Procedure: quality-of-life assessment Procedure: questionnaire administration Procedure: study of high risk factors Procedure: study of socioeconomic and demographic variables Procedure: survey administration

MedlinePlus related topics: Cancer Head and Neck Cancer Thyroid Cancer

Drug Information available for: Thyroid

Study Type:	Observational
Official Title:	Development and Implementation of The Thyroid Cancer Collaborative Registry (TCCR)

Further study details as provided by National Cancer Institute (NCI):

Primary Outcome Measures:

Development and implementation of a web-based Thyroid Cancer Collaborative Registry at the University of Nebraska Medical Center (UNMC)/Nebraska Medical Center (NMC) [ Designated as safety issue: No ]
Standardization of clinical, environmental, socio-demographic, and family history data for thyroid cancer research [ Designated as safety issue: No ]
Procurement and banking of excess biological material (i.e., thyroid tissue, tumor tissue and/or metastatic thyroid cancer tissue and/or paraffin embedded tissue) for future analysis [ Designated as safety issue: No ]
Collection and banking of blood and serum samples for future analysis that will be proposed in future IRB submissions [ Designated as safety issue: No ]
Establishment of a high-risk cohort for future research into the molecular and biological bases of thyroid cancer susceptibility and for interventional trials [ Designated as safety issue: No ]

Estimated Enrollment:	2000
Study Start Date:	February 2008

Eligibility

Criteria

DISEASE CHARACTERISTICS:

Meets either of the following criteria:
- Current diagnosis or history of thyroid cancer
- Presence of one or more thyroid nodules

PATIENT CHARACTERISTICS:

PRIOR CONCURRENT THERAPY:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00693368

Locations

United States, Nebraska
UNMC Eppley Cancer Center at the University of Nebraska Medical Center	Recruiting
Omaha, Nebraska, United States, 68198-6805
Contact: Clinical Trials Office - UNMC Eppley Cancer Center at the Univ 800-999-5465

Sponsors and Collaborators

University of Nebraska

National Cancer Institute (NCI)

Investigators

Principal Investigator:

Whitney S. Goldner, MD

University of Nebraska

More Information

Study ID Numbers:	CDR0000588891, UNMC-46307
Study First Received:	June 6, 2008
Last Updated:	December 31, 2008
ClinicalTrials.gov Identifier:	NCT00693368
Health Authority:	Unspecified

Keywords provided by National Cancer Institute (NCI):

thyroid cancer

Study placed in the following topic categories:

Thyroid Nodule
Thyroid Neoplasms
Head and Neck Neoplasms
Endocrine System Diseases

Endocrinopathy
Thyroid Diseases
Endocrine Gland Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on January 16, 2009